Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)

Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in those diseases or its treatments. Yet, a few studies was interested in, whereas platelet transfusion is the only treatment indicated. As it represent a scarce, limited resource, the ethical principles are in conflict in this setting and there's a lack of recommendation. The final decision is take by the clinician and his patient, but no study exist in representation of the two parts. We provide a qualitative study to understand what this decision is made of.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Platelet Transfusion Hematologic Diseases Hematologic Neoplasms Hematological Malignancy Hemic and Lymphatic Diseases Neoplasms Neoplasms by Site Palliative Care

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Moracchini

Besançon, 25000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

major patient
patient with advanced hematological malignancies
patient transfused in platelet regularly (3 time at least in last month)
medical practioner, hematologist, prescribing platelet transfusion at least one per week.
nurse working in hematology, practicing platelet transfusion at lest one peer week.

Exclusion criteria

minor patient
non communicant patient
non transfused platelet patient
non voluntary patient or hematologist or nurses
non graduated hematologist

Treatment and study plan

multi method questionary (developped by De Rosa, in 1995 and 2014)

Other

questions from an association network according to the subject and the grounded theorise (Glasser and Strauss)

Primary outcomes

measure the impact of social representation on platelet transfusion practice

Time frame: 3 months

inner core and peripheral items of platelet transfusion of each participant will be collected until reaching saturation, it's to say that the repetition of some terms will be measured between each interview thank's to a questionnaire of at least two principals opened questions.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Registry information

Acronym: R-PLQ

Important dates

Study start: 2019
Primary completion: 2019
Study completion: 2019
First posted: Jan 16, 2019
Registry last updated: Jul 25, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed